e-learning
resources
ERS Research Seminars
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Regulatory aspects of respiratory drugs
S. Bonini (London, United Kingdom)
Source:
Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Number:
10
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Bonini (London, United Kingdom). Regulatory aspects of respiratory drugs. Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Models of healthcare in respiratory diseases
Source: Breathe, 16 (3) 200213; 10.1183/20734735.0213-2020
Year: 2020
Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Regulatory status of COVID-19 vaccines
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021
Safety signals concerning asthma drugs in children
Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Year: 2017
Regulatory perspective on the use of lung imaging in drug development
Source: Eur Respir Monogr 2015; 70: 233-252
Year: 2015
Physiological effects associated with the use of respiratory devices
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014
Mechanisms and management of COPD exacerbations caused by respiratory mechanisms
Source: Annual Congress 2013 –MS1 Differential diagnosis and management of exacerbations of respiratory symptoms in elderly patients with COPD
Year: 2013
Physiological basis of respiratory problems in neuromuscular diseases
Source: International Congress 2019 – Sleep and neuromuscular diseases: assessment and management of respiratory problems
Year: 2019
Translating mechanisms to new drugs for COPD exacerbations
Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Year: 2009
Integrating systems biology in respiratory diseases
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016
Nutritional issues in patients with respiratory diseases
Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II
Year: 2014
Respiratory care in different situations: an overview of the epidemiology of respiratory diseases and their (co)morbidity
Source: Virtual Congress 2020 – Part II: From symptoms to diagnosis in primary care
Year: 2020
Improving the innate immune response in respiratory infections: the use of repurposed drugs
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020
Barriers to new drug development in respiratory disease
Source: Eur Respir J 2015; 45: 1197-1207
Year: 2015
Barriers to new drug development in respiratory disease
Source: Eur Respir J 2016; 47: 356-357
Year: 2016
Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229
Year: 2004
Economic aspects of enhanced testing strategies for respiratory diseases
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021
Mechanisms and management of COPD exacerbations caused by non-respiratory mechanisms
Source: Annual Congress 2013 –MS1 Differential diagnosis and management of exacerbations of respiratory symptoms in elderly patients with COPD
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept